Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In the latest episode of Circana Unpacked, Wei Lin Wong explores how shifts across categories are reshaping the marketplace
These lesions are often seen on the faces of older individuals
Improves texture and firmness, modestly
Based on these encouraging preliminary efficacy and safety signals, JSKN003 entered phase 3 trials in December 2023 (NCT06079983) [71]
And in fact, SURPASSCVOT is the first active comparator cardiovascular outcome trial in the type two diabetes setting
US$ 21.13
US$ 20.66
US$ 23.01
